Global reach BÜHLMANN operates with local teams across Europe, the USA, and Brazil and distributes worldwide, presenting a strong opportunity to upsell cross-border diagnostic solutions and leverage regional partnerships for multi-market contracts.

Calprotectin leadership As a leading provider of calprotectin tests with automated, high-throughput options (fCAL turbo) and ELISA (fCAL ELISA), there is significant sales potential to expand adoption in gastroenterology and inflammatory bowel disease pipelines among clinics and laboratories seeking scalable IBD diagnostics.

Strategic partnership Recent acquisition by KLAR Partners signals growth funding and expansion potential; this can be leveraged to introduce new product lines, accelerate validation trials, and pursue larger enterprise deployments with hospital networks and reference labs.

Quality and compliance Certified to EN ISO 13485:2016 and MDSAP with GMP manufacturing, enabling trust in regulated markets; target opportunities include export-ready labs and global distributors seeking compliant, ready-to-scale IVD solutions.

Academic and events Active participation in scientific congresses (EAACI, PNS) and poster presentations indicates a pathway to collaboration with research institutions and adoption of GanglioCombi and BAT-related testing in clinical studies and early-access programs.